Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,000
Closed -$4.4K 665
2024
Q2
$4.4K Buy
+1,000
New +$129K ﹤0.01% 529
2023
Q1
Sell
-36,700
Closed -$65.7K 646
2022
Q4
$65.7K Buy
+36,700
New +$3.75M 0.01% 240
2020
Q4
Sell
-7,336
Closed -$9K 491
2020
Q3
$9K Buy
+7,336
New +$575K ﹤0.01% 397

Other funds holding MRK

Cowen and Company's MRK Position: Q1 2023 in Review

Cowen and Company sold out of Merck (MRK) in Q1 2023, closing a stake of 24,969 shares — an estimated $2.77M sold.

Cowen and Company first reported a position in MRK in Q3 2019 and held it in 3 quarters. The position peaked at $2.77M in Q4 2022. 3,180 funds tracked by Wall St. Rank hold MRK as of Q1 2023.

  • Cowen and Company reported no remaining Merck position as of Q1 2023 after selling out during the quarter.
  • Cowen and Company sold 24,969 Merck shares in Q1 2023, an estimated $2.77M.
  • Cowen and Company first reported a position in Merck in Q3 2019 and held it in 3 quarters.
  • Cowen and Company's Merck position peaked at $2.77M in Q4 2022.
  • 3,180 funds tracked by Wall St. Rank held Merck as of Q1 2023.

Based on Cowen and Company's 13F filing for Q1 2023, filed 9 May 2023.